What a week in San Diego at DIA 2019! After arriving home late (or early Friday morning) and exhausted from the long journey, I still have an energy coursing through my veins fuelled by the week we left behind. As I reflect what the week meant for us, I feel an excitement about the future of both encapsia and our industry. Having observed the conference themes and the offerings from other vendors, I can’t help but feel there is nothing quite like encapsia.
It is now much easier for clinical trial sites to manage subject data as well as randomization, inventory management and drug dispensation. These processes can now be performed in real time using the single interface and unified database of encapsia, the clinical data suite developed by Cmed’s technology division. The breakthrough announced today has been made possible by a deep “hyper integration” between encapsia with leading-edge technology platforms PULSE and DRIVE from endpoint Clinical.
A recent survey on the challenges and opportunities in clinical data management by Pharma Intelligence reveals the most pressing issues today include the absence of real-time access to clinical trial data and that 90% of the effort involved in aggregating, cleaning and transforming data is manual. Moreover, over 80% of the respondents considered that incomplete and inconsistent data represents the top issue for regulatory compliance. Lastly, perhaps one of the most important findings was that eSource data is the future - finding ways to clean and manage new forms of data will be the next step in the progress of clinical trials.